ArticleResearch square2026
Race implications of COVID-19 in Utah: a population-based cohort study.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: The COVID-19 pandemic disproportionately affected marginalized populations in the United States. We characterize statewide COVID-19 health outcomes by race and ethnicity. Methods: We conducted a retrospective analysis of individuals alive on January 1, 2020 with known sex, race, and ethnicity data utilizing the Utah Population Database. COVID-19 health outcomes were identified by diagnostic codes. Ethnically diverse individuals were matched to non-Hispanic White (NHW) individuals by age and sex. Demographic characteristics were compared using Chi-square test. Conditional logistic regression models were used to estimate odds ratios (OR) for COVID-19 related outcomes with adjustment for potential confounders. Results: Among 1, 230, 862 individuals, 50% were NHW, 37% Hispanic/Latino, 2.6% Asian, 1.9% Black/ African American, 1.1% Native Hawaiian/ Pacific Islander (NHPI), 0.85% America Indian/ Alaskan Native (AIAN), and 6.6% multiracial. NHPI were the youngest, median age of 26. NHPIs had over a 4-fold increase in hospitalization and 11.28-fold higher odds of COVID-19-specific death compared to NHW. AIAN had more than 2-fold higher odds of hospitalization, ICU admission, death due to COVID-19 compared to NHW. Conclusions: Significant racioethnic disparities in COVID-19 health outcomes were observed in NHPI and AIAN populations and underscore the need for targeted public health strategies to mitigate disparities.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.